Hormone Refractory Prostate Cancer Recruiting Phase 2 Trials for Carboplatin (DB00958)

Back to Hormone Refractory Prostate Cancer

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone-Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030609 (Hormone Refractory Prostate Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02955082The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer TreatmentTreatment